About Merus Labs
Merus Labs was established in 2009 in Toronto, Canada, within the pharmaceuticals sector. Corporate growth is pursued through an opportunistic product acquisition strategy. The portfolio encompasses Sintrom for thromboembolic conditions, Enablex for overactive bladder, Salagen for radiation-induced dry mouth, and Vancocin capsules for bacterial infections like C. difficile. Operations focus on sourcing and integrating these treatments for womens health, cancer, infectious, and cardiovascular areas.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Merus Labs
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $20.0M
-
First Round
First Round
(23 Mar 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2016 | Amount | Post-IPO - Merus Labs | Valuation |
investors |
|
| Apr, 2015 | Amount | Post-IPO - Merus Labs | Valuation |
investors |
|
| Mar, 2014 | Amount | Post-IPO - Merus Labs | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Merus Labs
Merus Labs has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Norgine, PDL BioPharma and PowerOne Capital Markets. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Merus Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Merus Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Merus Labs Comparisons
Competitors of Merus Labs
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Merus Labs
When was Merus Labs founded?
Merus Labs was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is Merus Labs located?
Merus Labs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
What does Merus Labs do?
Merus Labs was established in 2009 in Toronto, Canada, within the pharmaceuticals sector. Corporate growth is pursued through an opportunistic product acquisition strategy. The portfolio encompasses Sintrom for thromboembolic conditions, Enablex for overactive bladder, Salagen for radiation-induced dry mouth, and Vancocin capsules for bacterial infections like C. difficile. Operations focus on sourcing and integrating these treatments for womens health, cancer, infectious, and cardiovascular areas.
Who are Merus Labs's investors?
Merus Labs has 3 investors. Key investors include Norgine, PDL BioPharma, and PowerOne Capital Markets.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.